Kindstar Global (9960) Stock Overview

Kindstar Globalgene Technology, Inc., together with its subsidiaries, provides clinical testing services in China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, China.